Bluebird Bio | BLUE - Current Liabilities


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview

Bluebird Bio

Bluebird Bio reported $115.93M in Current Liabilities for its fiscal quarter ending in March of 2023.


Current Liabilities Change
Agios Pharmaceuticals AGIO:US USD 45.11M 17.52M
Alnylam Pharmaceuticals ALNY:US USD 673.39M 94.52M
Amgen AMGN:US USD 14.22B 1.47B
Arrowhead Research ARWR:US USD 87.15M 34.86M
Avrobio Inc AVRO:US USD 14.3M 1.18M
Biogen BIIB:US USD 3.01B 257.9M
BioMarin Pharmaceutical BMRN:US USD 598.23M 9.35M
Bluebird Bio BLUE:US USD 115.93M 12.3M
Gilead Sciences GILD:US USD 10.53B 709M
Immunogen IMGN:US USD 101.63M 20.23M
Incyte Corp INCY:US USD 1.01B 150.97M
Intercept Pharmaceuticals ICPT:US USD 207.12M 22.96M
Ionis Pharmaceuticals IONS:US USD 259.22M 52.34M
Mirati Therapeutics MRTX:US USD 124.6M 34.85M
Moderna Inc MRNA:US USD 3.5B 1.42B
Nektar Therapeutics NKTR:US USD 59.88M 8.32M
Novartis NOVN:VX USD 30.55B 1.89B
PTC Therapeutics PTCT:US USD 441.63M 35.4M
Regeneron Pharmaceuticals REGN:US USD 3.1B 41.2M
Sangamo BioSciences SGMO:US USD 57.84M 53.87M
Sarepta Therapeutics SRPT:US USD 536.88M 82.72M
Seattle Genetics SGEN:US USD 713.23M 105.18M
Ultragenyx Pharmaceutical RARE:US USD 218.18M 43.03M
Vertex Pharmaceuticals VRTX:US USD 3.03B 284.1M